This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Thalamic Deep Brain Stimulation for Tourette Syndrome

This study has been completed.
Information provided by:
University Hospitals Cleveland Medical Center Identifier:
First received: April 5, 2006
Last updated: NA
Last verified: April 2006
History: No changes posted
The purpose of this study is to determine whether deep brain stimulation is effective at reducing tic frequency and severity in adults with Tourette syndrome.

Condition Intervention Phase
Tourette Syndrome Device: Thalamic deep brain stimulation Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double
Primary Purpose: Treatment
Official Title: Thalamic Deep Brain Stimulation for Tourette Syndrome: A Prospective Clinical Trial

Resource links provided by NLM:

Further study details as provided by University Hospitals Cleveland Medical Center:

Primary Outcome Measures:
  • modified Rush Video Rating Scale (mRVRS)
  • at defined points including baseline and 3 months

Secondary Outcome Measures:
  • tic counts (on video recording)
  • Yale Global Tourette Severity Scale (YGTSS)
  • Tourette Syndrome Symptom List (TSSL)
  • Quality of Life Visual Analog Scale (VAS)
  • SF-36
  • Neuropsychological battery

Estimated Enrollment: 5
Study Start Date: June 2005

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • age 18 or older
  • Diagnosis of Tourette Syndrome by DSM-IV
  • Tic frequency at least one per minute at screening
  • prior failure of at least two dopamine receptor or presynaptic blockers
  • negative impact on quality of life

Exclusion Criteria:

  • significant structural brain lesion (on imaging studies)
  • significant dementia
  • severe head trauma preceding onset of tics
  • use of dopamine receptor blockers prior to recognition of tics
  • prior implanted electrical device
  • electroconvulsive therapy (ECT) within 24 months
  • suicide attempt within 12 months
  • significant sociopathic personality
  • current or planned pregnancy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00311909

United States, Ohio
University Hospitals of Cleveland
Cleveland, Ohio, United States, 44106
Sponsors and Collaborators
University Hospitals Cleveland Medical Center
Principal Investigator: Robert J Maciunas, MD MPH FACS University Hospitals Cleveland Medical Center
  More Information Identifier: NCT00311909     History of Changes
Other Study ID Numbers: UHC DBS TS
Study First Received: April 5, 2006
Last Updated: April 5, 2006

Keywords provided by University Hospitals Cleveland Medical Center:
Tourette Syndrome
Deep Brain Stimulation
Video assessment

Additional relevant MeSH terms:
Tourette Syndrome
Pathologic Processes
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Tic Disorders
Movement Disorders
Heredodegenerative Disorders, Nervous System
Neurodegenerative Diseases
Genetic Diseases, Inborn
Neurodevelopmental Disorders
Mental Disorders processed this record on September 21, 2017